MIM
ABBV icon

Marco Investment Management’s AbbVie ABBV Stock Holding History

Marco Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3M Buy
139,533
+94
+0.1% +$20.9K 2.29% 10
2025
Q4 		$31.9M Sell
139,439
-1,740
-1% -$396K 2.39% 9
2025
Q3 		$32.7M Buy
141,179
+1,109
+0.8% +$226K 2.5% 9
2025
Q2 		$26M Buy
140,070
+2,414
+2% +$449K 2.17% 11
2025
Q1 		$28.8M Sell
137,656
-25,184
-15% -$4.9M 2.67% 7
2024
Q4 		$28.9M Buy
162,840
+22,649
+16% +$4.16M 2.5% 7
2024
Q3 		$27.7M Sell
140,191
-322
-0.2% -$60.1K 2.39% 9
2024
Q2 		$24.1M Buy
140,513
+12,807
+10% +$2.12M 2.22% 7
2024
Q1 		$23.3M Buy
127,706
+680
+0.5% +$117K 2.19% 10
2023
Q4 		$19.7M Buy
127,026
+492
+0.4% +$71.7K 2.02% 11
2023
Q3 		$18.9M Sell
126,534
-3,583
-3% -$526K 2.17% 11
2023
Q2 		$17.5M Sell
130,117
-27,975
-18% -$4.1M 1.89% 14
2023
Q1 		$25.2M Buy
158,092
+307
+0.2% +$46.9K 2.84% 4
2022
Q4 		$25.5M Sell
157,785
-230
-0.1% -$35.3K 2.98% 4
2022
Q3 		$21.2M Buy
158,015
+160
+0.1% +$23K 2.69% 5
2022
Q2 		$24.2M Sell
157,855
-10,282
-6% -$1.57M 2.81% 4
2022
Q1 		$27.3M Sell
168,137
-207
-0.1% -$30.1K 2.77% 3
2021
Q4 		$22.8M Sell
168,344
-581
-0.3% -$68.6K 2.24% 8
2021
Q3 		$18.2M Buy
168,925
+10,794
+7% +$1.23M 2.01% 14
2021
Q2 		$17.8M Buy
158,131
+3,205
+2% +$361K 2.07% 14
2021
Q1 		$16.8M Buy
154,926
+3,772
+2% +$403K 2.19% 14
2020
Q4 		$16.2M Buy
151,154
+22,259
+17% +$2.14M 2.33% 9
2020
Q3 		$11.3M Buy
128,895
+22,574
+21% +$2.13M 1.85% 16
2020
Q2 		$10.4M Buy
106,321
+23,894
+29% +$2.1M 1.91% 16
2020
Q1 		$6.28M Sell
82,427
-866
-1% -$73.8K 1.33% 25
2019
Q4 		$7.38M Sell
83,293
-207
-0.2% -$17.2K 1.14% 25
2019
Q3 		$6.32M Buy
83,500
+3,162
+4% +$217K 1.08% 26
2019
Q2 		$5.84M Buy
80,338
+675
+0.8% +$53.1K 1.04% 29
2019
Q1 		$6.42M Sell
79,663
-3,365
-4% -$275K 1.19% 25
2018
Q4 		$7.65M Sell
83,028
-1,708
-2% -$150K 1.52% 21
2018
Q3 		$8.01M Buy
84,736
+39
+0% +$3.7K 1.14% 27
2018
Q2 		$7.85M Buy
84,697
+433
+0.5% +$42.3K 1.22% 26
2018
Q1 		$7.98M Sell
84,264
-43,388
-34% -$4.77M 1.24% 25
2017
Q4 		$12.3M Sell
127,652
-19,297
-13% -$1.82M 1.88% 15
2017
Q3 		$13.1M Buy
146,949
+1,348
+0.9% +$103K 2.04% 11
2017
Q2 		$10.6M Sell
145,601
-995
-0.7% -$66.9K 1.74% 15
2017
Q1 		$9.55M Sell
146,596
-645
-0.4% -$40.6K 1.62% 16
2016
Q4 		$9.22M Buy
147,241
+33,480
+29% +$2.04M 1.61% 15
2016
Q3 		$7.17M Buy
113,761
+4
+0% +$259 1.29% 28
2016
Q2 		$7.04M Sell
113,757
-351
-0.3% -$21.4K 1.31% 27
2016
Q1 		$6.52K Buy
114,108
+1,300
+1% +$72.5K 0.94% 28
2015
Q4 		$6.68M Buy
112,808
+354
+0.3% +$20.4K 1.24% 25
2015
Q3 		$6.12M Sell
112,454
-806
-0.7% -$52.5K 1.21% 26
2015
Q2 		$7.61M Buy
113,260
+2,557
+2% +$167K 1.27% 25
2015
Q1 		$6.48M Buy
110,703
+2,242
+2% +$135K 1.12% 31
2014
Q4 		$7.1M Sell
108,461
-155
-0.1% -$9.77K 0.89% 28
2014
Q3 		$6.27M Buy
108,616
+1,093
+1% +$60.7K 0.87% 31
2014
Q2 		$6.07M Buy
107,523
+4,553
+4% +$239K 1.16% 29
2014
Q1 		$5.29M Buy
102,970
+715
+0.7% +$36.1K 1.1% 35
2013
Q4 		$5.4K Sell
102,255
-3,700
-3% -$182K 0.28% 34
2013
Q3 		$4.74M Buy
105,955
+6,500
+7% +$288K 1.09% 36
2013
Q2 		$4.11M Buy
+99,455
New +$4.35M 1.19% 32

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marco Investment Management's ABBV Position: Q1 2026 in Review

Marco Investment Management increased its AbbVie (ABBV) stake by 0.07% in Q1 2026, buying an estimated $20.9K and bringing the position to 139,533 shares worth $30.3M. The position accounts for 2.29% of the portfolio, ranked #10.

Marco Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.7M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Marco Investment Management held 139,533 shares of AbbVie worth $30.3M as of Q1 2026.
  • Marco Investment Management bought 94 AbbVie shares in Q1 2026, an estimated $20.9K.
  • AbbVie made up 2.29% of Marco Investment Management's portfolio in Q1 2026, its #10 holding.
  • Marco Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Marco Investment Management's AbbVie position peaked at $32.7M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.